Dietary B vitamin and methionine intake and MTHFR C677T genotype on risk of colorectal tumors in Lynch syndrome: the GEOLynch cohort study
Author(s) -
Audrey Jung,
Fränzel J. B. van Duijnhoven,
Fokko M. Nagengast,
Akke Botma,
Renate C Heine-Bröring,
Jan H. Kleibeuker,
Hans F. A. Vasen,
Jan L. Harryvan,
Renate M. Winkels,
Ellen Kampman
Publication year - 2014
Publication title -
cancer causes and control
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.073
H-Index - 134
eISSN - 1573-7225
pISSN - 0957-5243
DOI - 10.1007/s10552-014-0412-4
Subject(s) - medicine , methylenetetrahydrofolate reductase , vitamin b12 , hazard ratio , colorectal adenoma , colorectal cancer , methionine , gastroenterology , cohort , prospective cohort study , vitamin , proportional hazards model , b vitamins , genotype , physiology , confidence interval , cancer , biology , genetics , amino acid , gene
Dietary intake of B vitamins and methionine, essential components of DNA synthesis and methylation pathways, may influence colorectal tumor (CRT) development. The impact of B vitamins on colorectal carcinogenesis in individuals with Lynch syndrome (LS) is unknown but is important given their high lifetime risk of developing neoplasms. The role of MTHFR C677T genotype in modifying these relationships in LS individuals is also unclear. We investigated associations between dietary intakes of folate, vitamins B2, B6, B12, and methionine and CRT development in a prospective cohort study of 470 mismatch repair gene mutation carriers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom